179 related articles for article (PubMed ID: 10722569)
1. Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.
Russell ND; Corvalan JR; Gallo ML; Davis CG; Pirofski La
Infect Immun; 2000 Apr; 68(4):1820-6. PubMed ID: 10722569
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.
Chang Q; Zhong Z; Lees A; Pekna M; Pirofski L
Infect Immun; 2002 Sep; 70(9):4977-86. PubMed ID: 12183544
[TBL] [Abstract][Full Text] [Related]
3. Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.
Yano M; Pirofski LA
Clin Vaccine Immunol; 2011 Jan; 18(1):59-66. PubMed ID: 21068211
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.
Babb R; Doyle CR; Pirofski LA
Microbiol Spectr; 2021 Dec; 9(3):e0144621. PubMed ID: 34756090
[TBL] [Abstract][Full Text] [Related]
5. Immunogenetic analysis of the immune response to pneumococcal polysaccharide.
Baxendale HE; Davis Z; White HN; Spellerberg MB; Stevenson FK; Goldblatt D
Eur J Immunol; 2000 Apr; 30(4):1214-23. PubMed ID: 10760811
[TBL] [Abstract][Full Text] [Related]
6. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
Sun Y; Hwang Yi; Nahm MH
Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing.
Yano M; Gohil S; Coleman JR; Manix C; Pirofski LA
mBio; 2011; 2(5):. PubMed ID: 21917597
[TBL] [Abstract][Full Text] [Related]
8. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide.
Zhong Z; Burns T; Chang Q; Carroll M; Pirofski L
Infect Immun; 1999 Aug; 67(8):4119-27. PubMed ID: 10417182
[TBL] [Abstract][Full Text] [Related]
10. Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F.
Lucas AH; Granoff DM; Mandrell RE; Connolly CC; Shan AS; Powers DC
Infect Immun; 1997 Dec; 65(12):5103-9. PubMed ID: 9393802
[TBL] [Abstract][Full Text] [Related]
11. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4.
Musher DM; Johnson B; Watson DA
Infect Immun; 1990 Dec; 58(12):3871-6. PubMed ID: 2254015
[TBL] [Abstract][Full Text] [Related]
12. Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B.
Sun Y; Park MK; Kim J; Diamond B; Solomon A; Nahm MH
Infect Immun; 1999 Mar; 67(3):1172-9. PubMed ID: 10024557
[TBL] [Abstract][Full Text] [Related]
13. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.
Usinger WR; Lucas AH
Infect Immun; 1999 May; 67(5):2366-70. PubMed ID: 10225896
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.
Doyle CR; Pirofski LA
mBio; 2016 Feb; 7(1):e02260-15. PubMed ID: 26838726
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.
Fabrizio K; Manix C; Guimaraes AJ; Nosanchuk JD; Pirofski LA
Clin Vaccine Immunol; 2010 May; 17(5):713-21. PubMed ID: 20200186
[TBL] [Abstract][Full Text] [Related]
16. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy.
Subramaniam KS; Segal R; Lyles RH; Rodriguez-Barradas MC; Pirofski LA
J Infect Dis; 2003 Mar; 187(5):758-68. PubMed ID: 12599049
[TBL] [Abstract][Full Text] [Related]
17. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.
Ozdilek A; Huang J; Babb R; Paschall AV; Middleton DR; Duke JA; Pirofski LA; Mousa JJ; Avci FY
mBio; 2021 Jun; 12(3):e0080021. PubMed ID: 34061603
[TBL] [Abstract][Full Text] [Related]
18. Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B.
Zhou J; Lottenbach KR; Barenkamp SJ; Reason DC
Infect Immun; 2004 Jun; 72(6):3505-14. PubMed ID: 15155658
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.
Fabrizio K; Manix C; Tian H; van Rooijen N; Pirofski LA
Vaccine; 2010 Nov; 28(47):7542-50. PubMed ID: 20800700
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.
Chen Z; Cox KS; Tang A; Roman J; Fink M; Kaufhold RM; Guan L; Xie A; Boddicker MA; Mcguinness D; Xiao X; Li H; Skinner JM; Verch T; Retzlaff M; Vora KA
BMC Infect Dis; 2018 Dec; 18(1):613. PubMed ID: 30509199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
